AIFA - Allergy and Immunology Foundation of Australasia

AIFA - ACNC Registered Charity

A total of 27 expressions of interest for the 2019 AIFA research grants round were reecieved by the  deadline of 15 April 2019.  Due to the generous support of individuals, families and organisations over the past few years, more than $100,000 in AIFA grants will be awarded in 2019. The AIFA grants to be awarded at the closing function of the ASCIA 2019 Conference will include:

  • $40,000 - Food Allergy research grant
  • $30,000 - ASCIA 30th Anniversary research grant 
  • $25,000 - Primary Immunodeficiencies clinical research grant supported by CSL Behring
  • $10,000 - Food Allergy research grant supported by DBV Technologies

In 2020 more than $100,000 will again be awarded in AIFA research grants, due to the generous support of AIFA in 2019-2020.  To find out how to apply for an AIFA grant in 2020 go to 

The first AIFA grants were awarded in 2015 and by September 2019 a total of $265,000 in grants will have been awarded. For information about the projects awarded AIFA grants go to 

AIFA research grants are selected each year through a robust selection process, involving an independent, voluntary panel of leading experts.  Their track record in selecting projects is outstanding, with two projects funded by AIFA having since been recognised with further funding by the National Health and Medical Research Council (NHMRC).

Donate to AIFA now 

AIFA research grants encourage:

  • Early career researchers who may not yet receive grants from the NHMRC or other organisations
  • Research that requires seed funding
  • Collaborative research projects conducted throughout Australia and New Zealand
  • Projects that will translate to better treatment and care for patients with allergy and other immune diseases

pdfAIFA Leaflet1.06 MB

About AIFA

AIFA was established in 2013 by ASCIA, the peak professional body for allergy and clinical immunology in Australasia.  The aim of AIFA is to improve the health and care of people with allergy and other immune diseases by funding medical research and raising awareness of these disorders in Australia and New Zealand. 

Allergy and other immune system disorders (primary immunodeficiencies and autoimmune diseases) are amongst the most important chronic diseases and public health issues in Australia and New Zealand, affecting around 25% of the population. However, one of the greatest challenges for ASCIA and AIFA is the recognition by governments, authorities and funders of the importance of allergy and other immune diseases as top health priorities, in terms of patient care, training, education and research.  

Funding of research into allergy and other immune diseases is vital for the prevention and treatment of these diseases, and to ultimately find cures. This research can also impact other diseases, including immunotherapy based treatment options for other diseases.

As there are currently no cures for allergy and other immune diseases, training and education of health professionals, patients, carers and community is also extremely important. Increased recognition by governments, authorities and funders of the importance of  training and education has the potential to eliminate preventable deaths, disabilities and poor health outcomes due to allergy and other immune diseases.  For example:

  • Effective training and education programs about severe allergic reactions (anaphylaxis) and allergies to foods, drugs and insects can prevent life threatening anaphylaxis and therefore save lives and prevent disabilities.
  • Effective training and education programs on self administration of subcutaneous immunoglobulin (SCIg) replacement therapy for primary immunodeficiencies can help to minimise hospitalisations due to life threatening infections and complications. 

Content updated July 2019

Mod ASCIA Member
Donate to AIFA
go to NAS website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.


This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information.Verify here.